| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |